Navigation Links
Intelident Solutions Proposes to Acquire Zila for $0.42 per share in Cash
Date:7/7/2009

TAMPA, Fla., July 7 /PRNewswire/ -- Intelident Solutions, Inc. ("Intelident") today announced that it has submitted a proposal to the Board of Directors of Zila, Inc. (Nasdaq: ZILA) to acquire all of the common stock of Zila for $0.42 per share, and the preferred stock for $0.48 per share, or a total of approximately $4.4 million.

The proposal represents a premium for common stockholders of more than $418,000, or 10.5%, over the agreement with TOLMAR Holding, Inc. ("Tolmar"), and a premium of 31.3% over Zila's closing common stock price on June 24, 2009. The proposal would also include the purchase of the preferred shares of Zila at a premium of 9.1% over Tolmar's proposal.

"The proposed transaction will create a major dental company in the United States, combining Intelident's leadership in dental practice management with Zila's strength and experience in the prevention, detection, and treatment of oral cancer and periodontal disease," said Intelident CEO Thomas Marler. "This partnership will allow us to introduce a number of new and innovative products while accelerating the growth of the combined enterprise."

Marler continued, "The proposed transaction allows Zila's employees to join a company that is dedicated to advancements in oral care and disease prevention and has a well established reputation in the industry. As one of Zila's largest customers with a unique position as one of the largest dental practice management companies in the United States, we believe we can bring substantial strategic and tactical insight to expanding the sales of Zila's core product lines."

Intelident anticipates the transaction will close in September if its proposal is accepted.

About Intelident Solutions, Inc.

Intelident Solutions is a privately-held company dedicated to ad
'/>"/>

SOURCE Intelident Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management
2. Claimsnet Announces Claims Processing Agreement With New Health Care Solutions Company
3. ASAP Systems Announces the Launch of New Automated Alert and Notification Features for its Inventory, Assets and Evidence Solutions
4. SXC Health Solutions announces PBM contract with Presbyterian Health Plan
5. Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies
6. Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention
7. Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management
8. New Partnership Between FirstCare and HealthFitness Provides Cost-Effective Preventive Health Solutions for Small- to Mid-Size Companies
9. Finding solutions to the chronic nursing shortage
10. Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health
11. Focused Health Solutions Partners With Emmi Solutions to Help Employers Achieve Greater Returns on Their Employee Health Care Investments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... World Famous Lasik surgeo...k surgery to an ART in his pursuit for vision beyo...es an international clientel and is widely publish... Jacksonville, FL (PRWEB) November ...nstitute has been selected by Goldline Research a...
(Date:11/22/2009)... NEW YORK (Nov. 22 2009) -- Physician-scientists f...a molecular mechanism that may prove to be a power...homa, a type of cancer that affects lymphocytes, o... researchers have been able to powerfully suppress...ls. , Promising results have led to the design o...
(Date:11/22/2009)... HealthSmart, an innovativ...unced that it has successfully completed a recapit...Company’s other lenders. Silver Point Capit...enwich, Connecticut. This recapitalization allows...its business strategy. , , ...
(Date:11/22/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewswir...ollowing statement upon the United States Senate,s...ealth Care legislation: ,, "Senators Arlen Spec...ians and all Pennsylvanians for casting stand-up, ...sident Obama,s historic Affordable Health Care Ref...
(Date:11/21/2009)..., , "This bill provides for an unpreced... is health care about if it is not for preserving ...ded, it must be defeated." Charmaine Yoest ,...mericans United for Life Action President and CEO ... the Senate by releasing the following statement: ...
Breaking Medicine News(10 mins):Health News:Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States 2Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2
...HINGTON (30 May 2008) -- Legislation that IEEE-USA...ination in employment and health insurance based o.... , The Genetic Information Nondiscrimination Act...appreciation in a letter ( http://www.ieeeusa.org/...
...el Votes, 16-0, in Favor of Short-Term Treatment o...), CHICAGO, May 30 GlaxoSmithKline (NYSE: GSK )...rug Administration,s,Oncology Drugs Advisory Commi...ents with chronic idiopathic,thrombocytopenic purp...
... prevalence of pre-cancerous masses in the colon i... 49 years of age and those who are 50 to 59 years ... the official journal of the American Gastroentero...easing incidence of colon cancer at that age. Beca...
...RK, May 30 We know the damage the sun can do to,o...damaging rays?, Listen to this report from Transi...R.aspx?story=35173 , Registered journalists can a...aphics and,photos for free and unrestricted use at...
..., Calif., May 30 Edwards Lifesciences,Corporation...nologies to,treat advanced cardiovascular disease,...ons from the U.S. Food and Drug Administration (FD...pertain to preclinical bench testing and the clari...
...HESTER, Minn. -- Mayo Clinic researchers have deve...f two prominent tumor suppressor genes, p16 and p1... these genes were expressed at increased levels as...ging, while p19 stops that process. , The finding...
Other Medicine News:Health News:IEEE-USA-supported Genetic Information Nondiscrimination Act signed into law 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 2Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 3Health News:PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 4Health News:Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s 2Health News:Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s 3Health News:Edwards Lifesciences Receives Additional Questions From the FDA About the LifeStent Product Line 2
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 An ur...ectious diseases in the developing world has promp...mic researchers, non-profit product development pa...ology companies. As noted today in a symposium at ... Tropical Medicine and Hygiene (ASTMH), these coll...
(Date:11/20/2009)..., , CARY, N.C., Nov. 20 /PRNewswire-FirstCa...X ), a specialty pharmaceutical company focused on...cant products primarily for the respiratory and re... a Warning Letter from the Food and Drug Administr...le tablets (Phenylephrine HCl 10 mg, Pyrilamine Ma...
(Date:11/20/2009)..., , HARRISBURG, Pa., Nov. 20 /PRNewswire-U... providing free H1N1 flu shots to members of prior...e vaccine. ,, A total of 18 clinics are being h... are from 2 p.m. to 8 p.m. Hours on Saturday, Nov....the clinics will operate from 2 p.m. to 8 p.m. ,...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Fate Therapeutics announces creation of small molecule platform for commercial scale reprogramming 10409 1Fate Therapeutics announces creation of small molecule platform for commercial scale reprogramming 10409 2Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 1Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 2Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 3Florida Celebrates National Healthcare Quality Week 59698 1Florida Celebrates National Healthcare Quality Week 59698 2
...ANDS, Texas--(BUSINESS WIRE)--Jun 21, 2007 - Opexa...ved in the,development and commercialization of ce...ta in an open-label Phase I/II,extension clinical ...in(TM), for multiple sclerosis (MS). In this one-y...ng remitting (RRMS),and secondary progressive (SPM...
...ISCO & NEW DELHI, India--(BUSINESS WIRE)--Jun ...-based non-profit,pharmaceutical company, today an... approved drug product, Paromomycin IM,Injection (...f The,New England Journal of Medicine (NEJM). This...n is safe, effective, and well suited,to curing vi...
Other Medicine Technology:Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4
...nlike any trocar system you've ever seen., ,The O...ms in one designed to be versatile, operationally...eeds., ,By offering options in disposability and ...effectively address the individual preferences of ...
ENDOPATH Surgical Thoracic Trocar Sleeve with Rounded Tip Obturator
MultAcoice™ Metzenbaum Curved Scissors
MultAcoice™ Dissecting Scissors
Medicine Products: